Introduction
Microsporidia infect animals of virtually all phyla, and are particularly prevalent in fish and insects. Interest in these organisms grew tremendously during the past 20 years after being associated as a cause of persistent diarrhea and systemic disease in persons with AIDS [1] . Increased awareness and improved diagnostics have broadened our knowledge about the wide demographic, geographic, zoonotic, and environmental range of the species of microsporidia that infect humans. Identification of microsporidia in water sources also led to their inclusion on the National Institutes of Health (NIH) Category B list of biodefense pathogens and the Environmental Protection Agency (EPA) microbial contaminant candidates list of concern for waterborne transmission. The fairly recent completion of the Encephalitozoon cuniculi genome [2] has led to new insights into the molecular phylogeny and biology of the microsporidia. This review highlights research on microsporidiosis in humans published during the previous 2 years and the questions these findings raise.
Organism
The phylum, Microsporidia, includes approximately 1200 species that infect members of all animal phyla, and 14 of these can infect humans (Table 1) [3 ] . Enterocytozoon bieneusi and the Encephalitozoon spp. currently are the most prevalent microsporidia identified in humans. Microsporidia are single-celled intracellular parasites and infectious stages, or spores, of species that infect humans are small, measuring 1.0-3.0 mM Â 1.5-4.0 mM. Spore stages are surrounded by a glycoprotein outer layer and a chitinous inner layer that provide protection from the environment [4] . The cytoplasm of a microsporidian spore consists of a nucleus in a monokaryon or diplokaryon arrangement, an anterior anchoring disk, a membranous lamellar polaroplast that may include an atypical Golgi apparatus, polar vesicles that appear to be reduced mitochondria called mitosomes, endoplasmic reticulum, ribosomes, and a poster vacuole that may function as a peroxisome [5,6,7 ,8 ] . A coiled polar tube emanates from the anchoring disk and is a structure unique to the microsporidia that functions to facilitate infection of the host cell. A change in osmotic pressure results in swelling of the posterior vacuole and causes the polar tube to evert, followed by transfer of the cytoplasmic contents through the everting polar tube into the host cell ( Fig. 1 ).
Microsporidia were previously believed to be among the earliest or deep-branching eukaryotes because they lacked typical mitochondria, Golgi, and peroxisomes, and they possessed small ribosomes like those of prokaryotes [9]. This early divergence hypothesis was questioned on the basis of a long-branch attraction artefact of faster-evolving genes in these phylogenetic analyses, and today, the microsporidia are considered to be highly diverged, well adapted, and specialized parasites that are related or belong to the fungi [10,11 ,12,13]. Their exact relationship to the fungi, that is as a sister group, remains to be determined [14 ] . Through comparative genome analyses, microsporidia were observed to contain among the smallest genomes of eukaryotes which resulted from gene reduction and compaction [10,11 ,15 ,16 ] . For example, the Encephalitozoon cuniculi genome is 2.9 Mb and consists of approximately 2000 genes which are tightly packed having few introns, a shorter gene length and smaller protein size for homologous genes and proteins seen in other eukaryotes, and having overlapping gene-coding regions [6,15 ,16 ,17 ] . Microsporidia have lost many of the genes relating to metabolic and regulatory pathways, and retained those related to transport of energy sources and metabolites, presumably as a consequence of host cell dependence [6,10,11 ,12] . Identification of over a dozen genes encoding for mitochondrion-derived proteins and the localization of mitochondrial HSP70 to the mitosome support the likelihood that microsporidia evolved from ancestors that contained mitochondria. Phylogenetic analyses of multiple gene sequences, including those with lower evolution rates, continue to support a relation between the microsporidia and fungi, and more specifically, to the ascomycete and basidiomycete clade [13, 14 ] . Efforts are under way to obtain sequence data from the E. bieneusi genome (S. Tzipori, personal communication) and to continue comparative genome analyses between the microsporidia and other organisms to better understand the forces that impact genome reduction and compaction in relation to phylogenetics and evolution. The fairly recent application of comparative molecular phylogenetic analyses has generated new considerations about the taxonomic classification of many species within the phylum of Microsporidia that was historically based on ultrastructural features, biological and biochemical characters, and habitats [18 ,19 ] .
Clinical features
When the microsporidia were first identified in the setting of HIV-1 infection and diarrhea, there was some debate about whether they were truly pathogenic as these organisms were also detected in persons who did not have diarrhea or other symptoms typically associated with infection. This most likely is a reflection that the immune status of the host plays a role in the expression of clinical signs during infection. AIDS patients with less than 50 CD4þ T cells per mm 3 blood are most likely to experience persistent diarrhea, weight loss, and abdominal pain associated with E. bieneusi or E. intestinalis infections, whereas HIV-infected individuals receiving antiretroviral therapies, or non-HIV-infected individuals who may be immunologically naive to microsporidia (i.e. children or travelers) may develop diarrhea that subsequently resolves [20 ,21 ] . Replication of organisms in the villus epithelium of the small intestine, along with reduced villus height and surface area, appear to contribute to malabsorption that leads to the diarrhea [22] [23] [24] [25] . E. bieneusi infections may spread to the hepatobiliary system to cause cholangitis and a few pulmonary infections have been reported [23, 26] . Encephalitozoon spp. typically disseminate and infections have been identified in nearly every organ system, including a recently described fatal pulmonary infection in a bone marrow transplant recipient [27, 28 ] . Of interest are reports of less commonly detected microsporidia species in humans, including a case of Trachipleistophora anthropopthera cornea infection in an AIDS patient [29 ] and a fatal case of myositis in a women with rheumatoid arthritis, caused by Brachiola algerae (recently reclassified as Anncaliia algerae), a microsporidian that typically infects mosquitoes [30, 31, 32 ] . This latter case now raises the added potential for vectorborne transmission of microsporidiosis. There are also increasing numbers of case reports suggesting that microsporidia are an emerging cause of ocular infections, including contact lens wearers [33,34 , 35,36,37 ,38] .
Several questions still exist about clinical aspects and consequences of microsporidia infections in humans.
Transplacental transmission of E. cuniculi has been reported in carnivores and laboratory rodents, and was recently considered to be responsible for the deaths of newborn emperor and cotton-top tamarins in Europe and the Americas [39] [40] [41] . Similarities between human and nonhuman primates, as well as the ubiquitous nature of microsporidia, would support the possibility for transplacental transmission in humans, but this has not yet been documented or reported to occur. Questions still persist about why some microsporidia infections do not seem to correlate with expression of clinical signs. Lessons from microsporidia infections in other mammals may offer some answers. In immune-competent laboratory mice experimentally infected with E. cuniculi, for example, a mild ascites may develop during the acute phase of infection that subsequently resolves even though the infections remain persistent or chronic for the life of the animals. Rabbits likewise develop persistent infections with E. cuniculi and sometimes develop motor paralysis or torticolis (head tilt), but most often, remain asymptomatic [42 ] . It seems reasonable that otherwise healthy humans may also develop clinical signs of infection during the early or acute stages of infection, as reported in travelers with diarrhea in which symptoms subsequently resolved even though spore shedding continued [21 ] . No formal studies have been reported in humans, however, about whether microsporidia infections routinely persist in a latent state, if they may reactivate during conditions of immune compromise, or if persistently infected individuals can transmit infections to others at risk. An example that supports the latter possibility was a case report of microsporidial keratoconjunctivitis being transmitted by the donor corneal graft [34 ] . Microsporidiosis is being reported more frequently in solid organ transplant recipients, but it is not clear if the infections were transferred by the donor or acquired by the host during immunosuppressive therapy [43] . It seems important to determine if asymptomatic and persistent microsporidia infections occur in humans, and if so, improved and reliable diagnostic methods are needed for attempting to prevent transmission to others at risk or to reduce the potential for reactivation of infection. Many of the species of microsporidia infecting humans tend to disseminate, and since kidney is one of the more common sites of disseminated infection, examination of urine for the presence of microsporidia is likely to improve detection of systemic infections. In addition, if one considers that microsporidia spore shedding in feces or urine may be intermittent or at levels below detection by histochemistry or polymerase chain reaction (PCR), serological approaches may become feasible for diagnosing infections in immune-competent individuals.
Diagnostics
Transmission electron microscopy was used to confirm a diagnosis of microsporidiosis based on detecting the polar filament within spores, and is still important for demonstrating ultrastructural features that, along with newly applied molecular biology approaches, contribute to taxonomic organization of the microsporidia, as evidenced by the recent reclassification of Brachiola spp. to Anncaliia [19 ,32 ]. Histochemistry methods were then developed and applied to detecting microsporidia more efficiently in fluids (feces, urine, mucus) and tissues. These included application of fluorescent brighteners (e.g. Calcofluor White, Uvitex 2B, Fungifluor) that target the chitinous spore wall, modified (concentrated) trichrome staining used alone or in combination with Gram stain, and the Warthin-Starry silver stain [44] . Immunofluorescent antibody staining for species-specific identification has been somewhat limited, but the recent production of monoclonal antibodies to E. bieneusi, along with earlier reports of monoclonals to Encephalitozoon spp., should simplify and improve detection of microsporidia in clinical specimens [45 ,46] . PCR-based methods that typically utilized primers for amplification of microsporidial rDNA genes, have been routinely applied in research laboratories for improving both sensitivity and specificity, but are still not routinely applied in diagnostic laboratories [44] .
Recently, an oligonucleotide microarray system was reported for simultaneous detection of four species of human pathogenic microsporidia species in clinical specimens that should increase diagnostic throughput, at least in research laboratories [47 ] .
Since microsporidia infections are increasingly reported in relatively immune-competent individuals such as children, travelers, and the elderly, efforts are growing to develop serological tests using whole organisms or recombinant polar tube protein or spore wall protein as antigens, especially in cases in which the microsporidian species cannot be grown in culture [48,49 ,50,51 ,52] . Of interest is that the serologic response of humans to the polar tube has been demonstrated to include the glycoepitopes found on this structure [49 ,51 ] . The significance of such approaches is to detect subclinical infections in individuals who may transmit microsporidiosis to others at risk (e.g. as transplant donors) or who may develop a risk for reactivation of infection under conditions of immune compromise (e.g. aging). Serology has not been used to routinely detect microsporidiosis in humans due to variable expression of antibodies in immune-deficient individuals.
Generally speaking, however, microsporidiosis is still probably overlooked because organisms are quite small, requiring expertise by microscopists in diagnostics laboratories, and inhibitors of PCR found in many clinical specimens may confound interpretation of results. In addition, microsporidia are often not included in the routine differential diagnoses for diarrhea, and urine specimens are typically not evaluated for microsporidia as a potential cause of systemic infections. As the reports of microsporidiosis continue to increase worldwide and in a wider range of human populations, it is expected that a greater emphasis will need to be placed on recognizing such infections.
Epidemiology and sources of infection
Microsporidiosis in humans occurs worldwide, with prevalence rates ranging between 0 and 50% depending on the geographic region, method of diagnosis, and demographic characteristics of the population being studied [53] . Prior to the application of antiretroviral therapies, prevalence rates for microsporidiosis tended to be highest among HIV-infected individuals with diarrhea and less than 100 CD4þ T cells per mm 3 blood [24, 54 ] . In regions of South America, Africa, and Asia where antiretroviral therapies are not readily accessible, microsporidiosis has been consistently identified in HIV-infected patients with AIDS and additional risk factors that included poor sanitary conditions and exposure to animals [24,25,55,56 ,57,58] . Microsporidiosis continues to be increasingly recognized in non-HIV-infected persons such as travelers, children, the elderly, and organ transplant recipients [20 ,21 ,43, 59 -61 ].
The source of most microsporidia infections is still uncertain, but the genotypes that infect humans have now been identified in domestic, farm, and wild animals, which supports the finding that microsporidiosis is a zoonotic disease [42 ] . The associations between the risks for infection with microsporidia through occupational and recreational contact with water sources were recently reviewed [53] and these observations contributed to the inclusion of microsporidia as NIH Category B biodefense pathogens (http://www3.niaid.nih.gov/ biodefense/bandc_priority.htm) and EPA microbial contaminant candidates (http://www.epa.gov/safewater/ccl/ ccl2_list.html) of concern for waterborne transmission. There also appears to be an association between microsporidia and foodborne transmission as a consequence of contaminated irrigation water, and organisms have been identified on lettuce, parsley, cilantro, and strawberries in Costa Rica [62] . These observations supported the rationale for studies on the transport of microsporidia through sandy porous media for developing mathematical models to assess the potential of microsporidia contamination of potable water supplies [63 ] . There is no doubt that continued improvements in diagnostics and molecular epidemiology will improve our understanding about the modes of transmission and risk factors associated with acquiring microsporidiosis and these data can then be employed for the development of rational prevention strategies.
Immunology
The hypothesis that resistance to microsporidiosis depends upon functional T lymphocytes is based on the greater severity of disease in AIDS patients with declining CD4þ T-cell levels and the development of lethal experimental microsporidia infections in mice depleted of CD4þ and CD8þ T cells [64, 65] . Recent studies on experimental microsporidiosis in murine models and ex-vivo human studies demonstrated the importance of the proinflammatory (Th1) cytokines such as interferon (IFN)-g, tumor necrosis factor (TNF)-a, and interleukin (IL)-12, along with a role for nitric oxide, in resistance to Encephalitozoon spp. [66 ,67] . CD8aaþ intraepithelial lymphocytes were observed to increase rapidly after oral administration of E. cuniculi to mice. These cells appeared to participate in proinflammatory responses via IFN-g production and cytotoxic activity and also contributed to immune regulation via IL-10 secretion [65] . In addition, antibodies were reported to contribute to prolonging survival in severe combined immune deficiency (SCID) mice given E. cuniculi per os [68 ] . Virtually nothing is known about protective immune responses to E. bieneusi infections due to the lack of tissue culture and small animal models. Naturally occurring E. bieneusi infections have been reported in rhesus and pigtail macaques and these currently represent the only animal models that simulate infections observed in both immune-competent and immunedeficient humans [69, 70] .
Therapy and disinfection
Immune reconstitution with antiretroviral therapies has greatly reduced the occurrence of microsporidiosisassociated clinical symptoms in persons with HIV infection [24, 25, 71] , and a recent study suggested that aspartyl protease inhibitors of HIV also directly inhibited growth of E. intestinalis in tissue culture [72 ] . Albendazole, a benzimidazole that inhibits microtubule assembly, was effective against several microsporidia, including the Encephalitozoon spp. but was less effective against E. bieneusi [73, 74] . Fumagillin, an antibiotic and antiangiogenic compound produced by Aspergillus fumigatus, was more broadly effective against Encephalitozoon spp. and E. bieneusi but was toxic when administered systemically [75] . Recent therapeutic development studies have focused on compounds that target microsporidian polyamines (e.g. polyamine analogues), methionine aminopeptidase 2 (e.g. fumagillin-related compounds and analogues), chitin (e.g. nikkomycins), and topoisomerases (e.g. fluoroquinolones) [71,76,77,78 ,79] . These studies utilized Encephalitozoon spp. as the lack of tissue culture and small animal models for E. bieneusi have limited studies to directly identify effective compounds for this organism.
There are significant concerns about the potential of waterborne and foodborne transmission of microsporidia. Recent studies demonstrated successful disinfection of E. intestinalis in water using chlorine and ozone disinfection, successful disinfection of E. cuniculi in food by highpressure processing, and that exposure of E. cuniculi to bleach, ethanol, HiTor, or Roccal was effective at reducing infectivity of these organisms in a tissue culture model system [80] [81] [82] .
Conclusion
The tremendous growth in research on the microsporidia since their recognition as causes of opportunistic infections in AIDS patients has led to a greater appreciation for their ability to adapt and infect a wide range of animals, including humans. New information is challenging current paradigms about the biology of microsporidia infections and should result in a better definition of the consequences of infection and the development of effective preventive and therapeutic strategies.
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